Boemi, M <br/><br/>
Serum paraoxonase is reduced in type 1 diabetic patients compared to non-diabetic, first degree relatives; influence on the ability of HDL to protect LDL from oxidation.  [electronic resource] 

 -  Atherosclerosis  Mar 2001 
 - 229-35 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0021-9150 
<br/><br/><label>Standard No.: </label>10.1016/s0021-9150(00)00556-6  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Alleles<br/>Antioxidants--metabolism<br/>Apolipoproteins B--blood<br/>Aryldialkylphosphatase<br/>Cholesterol, LDL--blood<br/>Diabetes Mellitus, Type 1--genetics<br/>Esterases--blood<br/>Female<br/>Genotype<br/>Humans<br/>Lipoproteins, HDL--metabolism<br/>Lipoproteins, LDL--metabolism<br/>Male<br/>Oxidation-Reduction<br/>Polymorphism, Genetic<br/>Promoter Regions, Genetic--genetics